Non-vitamin K oral antagonist (NOAC) compared to vitamin K antagonist (VKA) in left ventricular thrombus.
Al-Kaf F, Al Basiri S, Al Ash'hab Y, Otain M, Al Askary H, Khushail AA, Robert AA, Al Fagih A.
Al-Kaf F, et al.
J Family Med Prim Care. 2024 Jun;13(6):2485-2490. doi: 10.4103/jfmpc.jfmpc_1905_23. Epub 2024 Jun 14.
J Family Med Prim Care. 2024.
PMID: 39027879
Free PMC article.
BACKGROUND: Thromboembolic events are serious left ventricular thrombus (LVT) complications. Despite the limitations of vitamin K antagonist (VKA) drugs, it continues to be the recommended oral anticoagulation for LVT. Recently, nonvitamin K oral antagonist (NOAC) h …
BACKGROUND: Thromboembolic events are serious left ventricular thrombus (LVT) complications. Despite the limitations of vitamin K ant …